BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34600163)

  • 1. Patterns of medication use and imaging following initial diagnosis of sarcoidosis.
    Simmering J; Stapleton EM; Polgreen PM; Kuntz J; Gerke AK
    Respir Med; 2021; 189():106622. PubMed ID: 34600163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome in sarcoidosis. The relationship of relapse to corticosteroid therapy.
    Gottlieb JE; Israel HL; Steiner RM; Triolo J; Patrick H
    Chest; 1997 Mar; 111(3):623-31. PubMed ID: 9118698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential additional benefit of infliximab in patients with chronic pulmonary sarcoidosis already receiving corticosteroids: a retrospective analysis from a randomized clinical trial.
    Judson MA; Baughman RP; Costabel U; Mack M; Barnathan ES
    Respir Med; 2014 Jan; 108(1):189-94. PubMed ID: 24361164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The late follow-up of chronic sarcoid patients previously treated with corticosteroids.
    Rizzato G; Montemurro L; Colombo P
    Sarcoidosis Vasc Diffuse Lung Dis; 1998 Mar; 15(1):52-8. PubMed ID: 9572002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sarcoidosis and granulomatous disease: observation].
    Valeyre D; Lebargy F
    Rev Mal Respir; 2006 Apr; 23(2 Pt 2):5S51-5S58. PubMed ID: 16788510
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of progressive pulmonary sarcoidosis with cyclosporin A. A randomized controlled trial.
    Wyser CP; van Schalkwyk EM; Alheit B; Bardin PG; Joubert JR
    Am J Respir Crit Care Med; 1997 Nov; 156(5):1371-6. PubMed ID: 9372647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Musculoskeletal and pulmonary outcomes of sarcoidosis after initial presentation of osseous involvement.
    Miller ER; Fanta CH; McSparron JI; Pan B; Coblyn JS; Sparks JA
    Sarcoidosis Vasc Diffuse Lung Dis; 2019; 36(1):60-73. PubMed ID: 30918438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of a randomized controlled trial to evaluate effectiveness of methotrexate versus prednisone as first-line treatment for pulmonary sarcoidosis: the PREDMETH study.
    Kahlmann V; Janssen Bonás M; Moor CC; van Moorsel CHM; Kool M; Kraaijvanger R; Grutters JC; Overgaauw M; Veltkamp M; Wijsenbeek MS;
    BMC Pulm Med; 2020 Oct; 20(1):271. PubMed ID: 33076885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapeutic management of pulmonary sarcoidosis.
    Fazzi P
    Am J Respir Med; 2003; 2(4):311-20. PubMed ID: 14719997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial.
    Baughman RP; Winget DB; Lower EE
    Sarcoidosis Vasc Diffuse Lung Dis; 2000 Mar; 17(1):60-6. PubMed ID: 10746262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No evidence found for an association between prednisone dose and FVC change in newly-treated pulmonary sarcoidosis.
    Broos CE; Poell LHC; Looman CWN; In 't Veen JCCM; Grootenboers MJJH; Heller R; van den Toorn LM; Wapenaar M; Hoogsteden HC; Kool M; Wijsenbeek MS; van den Blink B
    Respir Med; 2018 May; 138S():S31-S37. PubMed ID: 29137908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary sarcoidosis in children: a follow-up study.
    Baculard A; Blanc N; Boulé M; Fauroux B; Chadelat K; Boccon-Gibod L; Tournier G; Clement A
    Eur Respir J; 2001 Apr; 17(4):628-35. PubMed ID: 11401056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of short-course, low-dose corticosteroid therapy for acute pulmonary sarcoidosis exacerbations.
    McKinzie BP; Bullington WM; Mazur JE; Judson MA
    Am J Med Sci; 2010 Jan; 339(1):1-4. PubMed ID: 19996733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and Treatment of Pulmonary Sarcoidosis: A Review.
    Belperio JA; Shaikh F; Abtin FG; Fishbein MC; Weigt SS; Saggar R; Lynch JP
    JAMA; 2022 Mar; 327(9):856-867. PubMed ID: 35230389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical management of sarcoidosis. A 50-year experience at the Johns Hopkins Hospital.
    Johns CJ; Michele TM
    Medicine (Baltimore); 1999 Mar; 78(2):65-111. PubMed ID: 10195091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of mycophenolate mofetil in sarcoidosis.
    Hamzeh N; Voelker A; Forssén A; Gottschall EB; Rose C; Mroz P; Maier LA
    Respir Med; 2014 Nov; 108(11):1663-9. PubMed ID: 25301291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticosteroids for pulmonary sarcoidosis.
    Paramothayan NS; Jones PW
    Cochrane Database Syst Rev; 2000; (4):CD001114. PubMed ID: 11034698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial Cardiac FDG-PET for the Diagnosis and Therapeutic Guidance of Patients With Cardiac Sarcoidosis.
    Ning N; Guo HH; Iagaru A; Mittra E; Fowler M; Witteles R
    J Card Fail; 2019 Apr; 25(4):307-311. PubMed ID: 30825644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical aspects of pulmonary sarcoidosis.
    Judson MA
    J S C Med Assoc; 2000 Jan; 96(1):9-17. PubMed ID: 10670174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.